Crommy and Pouges
The interim license if granted could open the door for some other African countries - but to be honest I can't see them spending capital in producing the stuff when it is clearly their intention to sell the project
In relation to the legal fee's JINLA may well be right if you include the fee's paid for advice concerning Berlin Pharma in Germany
My theory about the takeover of the company is mine and not something I have taken from anything said to me by management but makes commercial sense in my view
Rhani - I would love to attend such a party - the EMS ride has been a long and bumpy one for me and it would be great to meet the new and the old supporters of this company
Clyde
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable